Analysis of quasispecies in the viral 5? untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa
- 17 November 2004
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (12) , 923-926
- https://doi.org/10.1007/s10096-004-1238-x
Abstract
In the study presented here the ribavirin mutagenic effect was investigated by analyzing quasispecies in the viral 5′ untranslated region of hepatitis C virus in six patients with chronic infection who started interpheron-α and ribavirin therapy. A remarkable mutation rate during treatment was found in only one individual. This patient had a sustained response and harbored a type 3a virus strain. The different mutated clones in this patient demonstrated no apparent close relationship that could suggest lack of selection pressure by ribavirin. The mutations were located within the loops of subdomains IIIb and IIId of the internal ribosomal entry site. This is an interesting initial finding that needs to be substantiated in a larger trial.Keywords
This publication has 16 references indexed in Scilit:
- Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication SystemJournal of Virology, 2002
- Quasispecies Heterogeneity and Constraints on the Evolution of the 5′ Noncoding Region of Hepatitis C Virus (HCV): Relationship with HCV Resistance to Interferon-α TherapyVirology, 2002
- Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcomeProceedings of the National Academy of Sciences, 2002
- Longitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C PatientsJournal of Virology, 2001
- RNA virus error catastrophe: Direct molecular test by using ribavirinProceedings of the National Academy of Sciences, 2001
- Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis CJournal of Clinical Virology, 2001
- THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS: Genotypes and QuasispeciesClinics in Liver Disease, 1999
- Hepatitis C viral quasispeciesJournal of Viral Hepatitis, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998